Skin collagen synthesis is depressed in patients with severe sepsis

Anesthesia and Analgesia

Volumn 111, Issue 1, 2010, Pages 156-163

  Gäddnäs, Fiia P ^a   Koskela, Marjo ^a   Koivukangas, Vesa ^a   Laurila, Jouko ^a   Saarnio, Juha ^a   Risteli, Juha ^a   Oikarinen, Aarne ^a   Ala Kokko, Tero ^a  

^a OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGENASE; LACTIC ACID; COLLAGEN; PROCOLLAGEN;

ABDOMEN; ABDOMINAL INFECTION; ADULT; AGED; AMINO TERMINAL SEQUENCE; APACHE; ARTICLE; BLISTER; CLINICAL ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DISEASE SEVERITY; ENZYME SYNTHESIS; FEMALE; GENE OVEREXPRESSION; HOSPITAL ADMISSION; HUMAN; LENGTH OF STAY; LUNG INFECTION; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEPSIS; SEPTIC SHOCK; URINARY TRACT INFECTION; BIOSYNTHESIS; INTENSIVE CARE; LABORATORY DIAGNOSIS; METABOLISM; MIDDLE AGED; SKIN; TREATMENT OUTCOME;

AGED; COLLAGEN; COLLAGEN TYPE I; COLLAGEN TYPE III; FEMALE; HUMANS; INTENSIVE CARE; LACTIC ACID; MALE; MIDDLE AGED; PROCOLLAGEN; PROSPECTIVE STUDIES; SEPSIS; SKIN; SPECIMEN HANDLING; TREATMENT OUTCOME;

EID: 77954666866     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e3181e1db48     Document Type: Article

References (39)

1. Ahrendt GM, Gardner K, Barbul A. Loss of colonic structural collagen impairs healing during intra-abdominal sepsis. Arch Surg 1994;129:1179-83
2. Clark MA, Plank LD, Hill GL. Wound healing associated with severe surgical illness. World J Surg 2000;24:648-54
3. Thornton FJ, Ahrendt GM, Schaffer MR, Tantry US, Barbul A. Sepsis impairs anastomotic collagen gene expression and synthesis: a possible role for nitric oxide. J Surg Res 1997;69:81-6 (Pubitemid 27265831)
4. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101:1644-55
5. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003;348:138-50
6. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G, SCCM/ESICM/ACCP/ATS/SIS. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003;31:1250-6 (Pubitemid 36444440)
7. Cooney R, Iocono J, Maish G, Smith JS, Ehrlich P. Tumor necrosis factor mediates impaired wound healing in chronic abdominal sepsis. J Trauma 1997;42:415-20
8. Shahin ES, Dassen T, Halfens RJ. Pressure ulcer prevalence and incidence in intensive care patients: a literature review. Nurs Crit Care 2008;13:71-9
9. Compton F, Hoffmann F, Hortig T, Strauss M, Frey J, Zidek W, Schafer JH. Pressure ulcer predictors in ICU patients: nursing skin assessment versus objective parameters. J Wound Care 2008;17:417-20, 422-4
10. Maish GO III, Shumate ML, Ehrlich HP, Cooney RN. Tumor necrosis factor binding protein improves incisional wound healing in sepsis. J Surg Res 1998;78:108-17
11. Rico RM, Ripamonti R, Burns AL, Gamelli RL, Di Pietro LA. The effect of sepsis on wound healing. J Surg Res 2002;102:193-7
12. Haukipuro K, Risteli L, Kairaluoma MI, Risteli J. Aminoterminal propeptide of type III procollagen in healing wound in humans. Ann Surg 1987;206:752-6
13. Dayer JM, Beutler B, Cerami A. Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J Exp Med 1985;162:2163-8
14. Rapala KT, Vaha-Kreula MO, Heino JJ, Vuorio EI, Laato MK. Tumor necrosis factor-alpha inhibits collagen synthesis in human and rat granulation tissue fibroblasts. Experientia 1996;52:70-4
15. Broughton G II, Janis JE, Attinger CE. Wound healing: an overview. Plast Reconstr Surg 2006;117:1e-S-32e-S
16. Higgins DF, Kimura K, Bernhardt WM, Shrimanker N, Akai Y, Hohenstein B, Saito Y, Johnson RS, Kretzler M, Cohen CD, Eckardt KU, Iwano M, Haase VH. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest 2007;117:3810-20
17. Noritomi DT, Soriano FG, Kellum JA, Cappi SB, Biselli PJ, Liborio AB, Park M. Metabolic acidosis in patients with severe sepsis and septic shock: a longitudinal quantitative study. Crit Care Med 2009;37:2733-9
18. Koskela M, Gäddnäs F, Ala-Kokko T, Laurila J, Saarnio J, Oikarinen A, Koivukangas V. Experimental wound healing in severe sepsis and septic shock in humans. Crit Care 2008;12: P390
19. Oikarinen A, Autio P, Kiistala U, Risteli L, Risteli J. A new method to measure type I and III collagen synthesis in human skin in vivo: demonstration of decreased collagen synthesis after topical glucocorticoid treatment. J Invest Dermatol 1992;98:220-5
20. Vermeer BJ, Reman FC, van Gent CM. The determination of lipids and proteins in suction blister fluid. J Invest Dermatol 1979;73:303-5
21. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Levy MM, Surviving Sepsis Campaign Management Guidelines Committee. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004;32:858-73
22. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996;22:707-10
23. Vincent JL, de Mendonca A, Cantraine F, Moreno R, Takala J, Suter PM, Sprung CL, Colardyn F, Blecher S. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med 1998;26:1793-800
24. Kiistala U. Suction blister device for separation of viable epidermis from dermis. J Invest Dermatol 1968;50:129-37
25. Melkko J, Kauppila S, Niemi S, Risteli L, Haukipuro K, Jukkola A, Risteli J. Immunoassay for intact amino-terminal propeptide of human type I procollagen. Clin Chem 1996;42:947-54
26. Gäddnäs F, Koskela M, Koivukangas V, Risteli J, Oikarinen A, Laurila J, Saarnio J, Ala-Kokko T. Markers of collagen synthesis and degradation are increased in serum in severe sepsis: a longitudinal study of 44 patients. Crit Care 2009;13: R53
27. Meduri GU, Tolley EA, Chinn A, Stentz F, Postlethwaite A. Procollagen types I and III aminoterminal propeptide levels during acute respiratory distress syndrome and in response to methylprednisolone treatment. Am J Respir Crit Care Med 1998;158:1432-41
28. Clark JG, Milberg JA, Steinberg KP, Hudson LD. Type III procollagen peptide in the adult respiratory distress syndrome. Association of increased peptide levels in bronchoalveolar lavage fluid with increased risk for death. Ann Intern Med 1995;122:17-23
29. Ihlberg L, Haukipuro K, Risteli L, Oikarinen A, Kairaluoma MI, Risteli J. Collagen synthesis in intact skin is suppressed during wound healing. Ann Surg 1993;217:397-403
30. Osuchowski MF, Welch K, Siddiqui J, Remick DG. Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J Immunol 2006;177:1967-74
31. Thornton SC, Por SB, Walsh BJ, Penny R, Breit SN. Interaction of immune and connective tissue cells: I. The effect of lymphokines and monokines on fibroblast growth. J Leukoc Biol 1990;47:312-20
32. Autio P, Oikarinen A, Melkko J, Risteli J, Risteli L. Systemic glucocorticoids decrease the synthesis of type I and type III collagen in human skin in vivo, whereas isotretinoin treatment has little effect. Br J Dermatol 1994;131:660-3
33. Oikarinen A, Autio P, Kiistala U, Risteli L, Risteli J. A new method to measure type I and III collagen synthesis in human skin in vivo: demonstration of decreased collagen synthesis after topical glucocorticoid treatment. J Invest Dermatol 1992;98:220-5
34. Schroeder S, Wichers M, Klingmuller D, Hofer M, Lehmann LE, von Spiegel T, Hering R, Putensen C, Hoeft A, Stuber F. The hypothalamic-pituitary-adrenal axis of patients with severe sepsis: altered response to corticotropin-releasing hormone. Crit Care Med 2001;29:310-6
35. Kubli S, Boegli Y, Ave AD, Liaudet L, Revelly JP, Golay S, Broccard A, Waeber B, Schaller MD, Feihl F. Endotheliumdependent vasodilation in the skin microcirculation of patients with septic shock. Shock 2003;19:274-80
36. Hoffmann JN, Vollmar B, Inthorn D, Schildberg FW, Menger MD. A chronic model for intravital microscopic study of microcirculatory disorders and leukocyte/endothelial cell interaction during normotensive endotoxemia. Shock 1999;12:355-64
37. Trabold O, Wagner S, Wicke C, Scheuenstuhl H, Hussain MZ, Rosen N, Seremetiev A, Becker HD, Hunt TK. Lactate and oxygen constitute a fundamental regulatory mechanism in wound healing. Wound Repair Regen 2003;11:504-9
38. Broughton G II, Janis JE, Attinger CE. The basic science of wound healing. Plast Reconstr Surg 2006;117:12S-34S
39. Gertzberg N, Gurnani T, Neumann P, Forbes AK, Jean-Louis N, Johnson A. Tumor necrosis factor-alpha causes barrier dysfunction mediated by tyrosine198 and tyrosine218 in betaactin. Am J Physiol Lung Cell Mol Physiol 2007;293: L1219-29